BIO Suggests Re-Evaluation Of Continuous Marketing Application Programs
Executive Summary
FDA's continuous marketing application pilot programs may not be worth continuing, the Biotechnology Industry Organization suggested
You may also be interested in...
PDUFA Provides Opportunity For Conditional Approvals, Consumer Groups Say
Consumer groups are advocating the creation of a "conditional" approval authority for FDA through the reauthorization of the Prescription Drug User Fee Act
PDUFA Provides Opportunity For Conditional Approvals, Consumer Groups Say
Consumer groups are advocating the creation of a "conditional" approval authority for FDA through the reauthorization of the Prescription Drug User Fee Act
PDUFA IV: FDA Stresses Burden Of Industry Meetings In User Fee Discussions
FDA is emphasizing the difficulties of industry requested meetings in its early public discussion of the 2007 Prescription Drug User Fee Act reauthorization